STOCK TITAN

PRF Technologies and Dotz Nano Sign Term Sheet for Strategic Collaboration to Expand AI-Driven Energy Optimization Offering

Dotz would fund GridFeed operations from closing, while PRF would retain exposure through a proposed equity investment.

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
partnership AI

PRF Technologies (PRFX) signed a non-binding term sheet for Dotz Nano to commercialize and acquire its GridFeed energy platform for US$1.0 million. Dotz would operate GridFeed under an exclusive license from closing, with ownership and intellectual property transferring after US$650,000 is paid. PRF would invest US$250,000 in Dotz’s recently announced A$2.0 million placement. Dotz would employ the GridFeed team and fund operations from closing. Completion requires due diligence, both boards’ approval and definitive agreements.

PRF plans to direct resources toward healthcare programs. Preliminary, unaudited cash, including short-term deposits, was approximately US$11.0 million at September 30, 2026. Its majority-owned LayerBio subsidiary expects enrollment in the U.S. multi-center Phase 2 trial of OcuRing-K to begin before year-end. PRF also continues to advance its PRF-110 post-surgical pain candidate.

Loading...
Loading translation...
7 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate point. Forward-looking: it has not happened yet and may not happen.Proposed GridFeed sale to Dotz would provide PRF with US$1.0 million. 38% of market cap
  • Minor point. Forward-looking: it has not happened yet and may not happen.Dotz would employ the GridFeed team and fund operations from closing.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Proposed Dotz equity position would give PRF continued participation in potential commercialization value.
  • Minor pointGridFeed engine was validated during 2026 using real-world European utility-scale production, weather and market data.
  • Minor point. Forward-looking: it has not happened yet and may not happen.LayerBio expects U.S. multi-center Phase 2 enrollment for OcuRing-K to begin before year-end.
2 minor points
  • Minor point. Forward-looking: it has not happened yet and may not happen.PRF plans to direct resources toward LayerBio and healthcare portfolio expansion.
  • Minor pointPRF continues to advance PRF-110, its extended-release, opioid-sparing post-surgical pain candidate.

Negative

  • Moderate pointGridFeed transaction remains non-binding, pending due diligence, both boards’ approval and definitive agreements.
  • Moderate point. Forward-looking: it has not happened yet and may not happen.Proposed Dotz equity investment would require US$250,000 from PRF. 9.5% of market cap
Argus 15 min delay 24 alerts
-1.95% vs previous close $0.6971 last price 110.7x rel. volume Open Argus
Details

Market Reaction – PRFX

+22.5% Peak in 1 min
$0.68 – $0.98 Day Range
$2.44M Mkt Cap at Last Price

On Nov 3, the day this news came out, the latest delayed price for PRFX is 1.95% below the previous close. Argus tracked a peak move of +22.5% during the session. Our momentum scanner has recorded 24 alerts for this stock so far that day. The latest delayed price is $0.70. Relative volume is exceptionally heavy at 110.7x the stock’s average daily volume.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

GridFeed purchase price: US$1.0 million Dotz placement participation: US$250,000 Dotz placement size: A$2.0 million +1 more
GridFeed purchase price
US$1.0 million
Proposed platform acquisition by Dotz
Dotz placement participation
US$250,000
PRF participation in Dotz's recently announced placement
Dotz placement size
A$2.0 million
Recently announced placement
Payment threshold for platform transfer
US$650,000
Platform ownership and intellectual property would transfer after this amount is paid

Previous Partnership,AI Reports

1 past event · Latest: Sep 09
Same Type 1 event
  1. Sep 09

    GridFeed subsidiary plan

    24h Move
    +0.6%

    PRF planned a standalone GridFeed subsidiary to pursue commercialization and strategic alliances.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

non-binding term sheet, exclusive license, phase 2 clinical trial, bio-erodible
4 terms
non-binding term sheet financial
"signed a non-binding term sheet with Dotz Nano Limited"
A non-binding term sheet is a written outline of the main points parties expect to agree on in a business deal, like price, structure and timing, but it is not a final, enforceable contract. Think of it as a handshake on paper that sets expectations and a roadmap for negotiation and due diligence. Investors watch these because they signal intent and basic economics of a potential transaction, but terms can change before a binding agreement is signed, so the initial outline is informative but not guaranteed.
exclusive license financial
"launch GridFeed in the market under an exclusive license from PRF"
An exclusive license is a legal agreement that gives one party the sole right to use, make, sell or commercialize a product, technology, patent, or other intellectual property, while the owner keeps ultimate ownership. Think of it like leasing a unique tool to a single tenant: that tenant alone can profit from it for the license term. Investors care because exclusivity can create predictable revenue streams, affect competitive position, valuation, and the likelihood of future royalties or milestone payments.
phase 2 clinical trial medical
"U.S. multi-center Phase 2 clinical trial of OcuRing™-K"
A phase 2 clinical trial is a research study that tests a new medical treatment or drug to see if it is effective and safe for a specific condition. It involves a larger group of people than earlier trials and helps determine whether the treatment should move forward to more extensive testing. For investors, successful phase 2 results can signal potential for future approval and commercial success, while setbacks may indicate challenges ahead.
bio-erodible medical
"a patent-protected, bio-erodible intraocular ring"
A material engineered to break down progressively when placed in a living body so that it loses mass and structural integrity over time through chemical reactions (for example hydrolysis) and biological processes (such as enzymatic action), producing smaller molecules or particles that are absorbed, dissolved, or eliminated by normal physiological pathways; commonly used for temporary implants and drug-delivery systems where the device or carrier is intended to disappear after performing its function. The rate and byproducts of erosion depend on the material's chemistry and environment, and being bio-erodible does not by itself guarantee that the breakdown products are harmless or cleared rapidly without causing a tissue response.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Proposed transaction combines PRF’s DeepSolar/GridFeed™ renewable energy forecasting and storage optimization platform with Dotz’s AI-driven energy management technologies, creating an expanded offering across energy consumption, generation and trading

Dotz to launch GridFeed in the market under an exclusive license and acquire the platform for US$1.0 million, with PRF taking an equity position in Dotz

TEL AVIV, Israel, Nov. 03, 2026 (GLOBE NEWSWIRE) -- PRF Technologies Ltd. (Nasdaq: PRFX) (“PRF” or the “Company”) today announced that it has signed a non-binding term sheet with Dotz Nano Limited (ASX: DTZ) (“Dotz”) for a strategic collaboration aimed at expanding Dotz’s presence in the rapidly evolving AI-driven energy optimization market. PRF believes the collaboration marks the next stage of growth for GridFeed™, which has matured to the point where it is ready to be taken to market by a dedicated commercialization partner.

The proposed transaction would combine PRF’s GridFeed™ AI platform, which provides advanced renewable energy generation forecasting, battery storage optimization and electricity market trading intelligence, with Dotz Energy’s existing AI-driven energy optimization technologies for commercial and industrial energy consumers.

Dotz would commercialize and ultimately acquire PRF’s DeepSolar/GridFeed™ AI energy platform for US$1.0 million, and the parties are working toward definitive agreements. Dotz would launch GridFeed in the market under an exclusive license from PRF, and PRF would take an equity position in Dotz through a US$250,000 participation in Dotz’s recently announced A$2.0 million placement. Dotz is a climate-technology company listed on the Australian Securities Exchange with operations in Israel, which is commercializing technologies designed to reduce energy consumption. Its Dotz Energy business focuses on AI-driven energy optimization, managed energy infrastructure and related software applications.

Strategic Rationale

Since acquiring the DeepSolar business in March 2025, PRF’s team has developed it into GridFeed™, an AI-driven platform for renewable energy forecasting, battery storage optimization and electricity market trading. During 2026, the GridFeed engine was validated using real-world European utility-scale production, weather and market data, the platform was extended into battery energy storage, and DeepSolar was accepted into the NVIDIA Connect program. In September, PRF announced plans to establish GridFeed as a standalone subsidiary to pursue strategic transactions, and the agreement with Dotz is the result of that process.

The strategic opportunity extends beyond the commercialization of an additional software platform. The proposed collaboration brings together two complementary areas of energy technology that address different but interconnected parts of the energy value chain.

Dotz Energy’s ChillerAI platform focuses on optimizing energy consumption, helping large commercial and industrial facilities reduce electricity costs through AI-driven management of their cooling infrastructure. GridFeed addresses the supply side of the equation, providing intelligence to forecast renewable energy generation, optimize battery storage utilization and support decisions regarding electricity market participation.

The combination has the potential to expand Dotz Energy’s capabilities beyond individual building-level energy optimization into a broader energy intelligence offering, connecting consumption management with renewable energy generation, storage and electricity market optimization.

Importantly, these technologies address an increasingly interconnected energy environment in which the ability to optimize not only how energy is consumed, but also when and how it is generated, stored and traded, can create additional opportunities for efficiency and economic value.

The collaboration could also create opportunities to leverage Dotz’s existing commercial relationships and market presence to accelerate the introduction of GridFeed to potential customers, while providing Dotz with access to additional technology capabilities and specialized expertise in renewable energy and electricity markets.

PRF believes that collaborating with Dotz will allow GridFeed to benefit from Dotz’s experience in energy technology and its commercialization capabilities. Dotz is advancing ChillerAI commercially, including a memorandum of understanding with Thanos Hotels covering three luxury hotels in Cyprus and a signed pilot arrangement with MyMall in Limassol. From closing, Dotz would employ the GridFeed team and fund the platform’s operations, and through its equity position, PRF would participate in any value Dotz creates as it commercializes the combined technology.

Efraim Cohen-Arazi, Interim Chief Executive Officer of PRF Technologies, commented, “Our team has developed GridFeed into a validated AI energy platform, and this agreement marks the next stage of its growth. Dotz brings the energy focus and commercialization capabilities to take GridFeed to market, along with a complementary business that optimizes energy use in commercial buildings. The agreement would provide PRF with US$1.0 million and an equity position in Dotz, giving our shareholders continued participation in GridFeed’s success, while allowing us to direct our own resources to LayerBio and the Phase 2 trial of OcuRing™-K, and to expanding our portfolio of healthcare innovations.”

Nati Harpaz, Chief Executive Officer of Dotz, added, “We are moving decisively further into the energy space, bringing together AI-driven optimization of how buildings consume energy with the intelligence needed to better understand and manage the generation and distribution of renewable power. The proposed GridFeed acquisition would accelerate this strategy by adding an established software platform and specialist expertise to our growing Dotz Energy offering.”

Transaction Terms

Under the term sheet, Dotz would operate and commercialize GridFeed under an exclusive license from PRF from closing, and ownership of the platform and its intellectual property would transfer to Dotz once US$650,000 of the purchase price has been paid. Completion of the transaction is subject to due diligence, approval by the boards of directors of both companies, and the execution of definitive agreements.

Focus on Healthcare Programs

With preliminary, unaudited cash, including short-term deposits, of approximately US$11.0 million as of September 30, 2026, PRF is focused on its healthcare programs. LayerBio, PRF’s majority-owned subsidiary, expects to begin enrolling patients in its U.S. multi-center Phase 2 clinical trial of OcuRing™-K before year-end. OcuRing™-K is a patent-protected, bio-erodible intraocular ring designed to deliver ketorolac through a single application during cataract surgery, with the potential to eliminate the need for complex post-operative eye-drop regimens. PRF also continues to advance PRF-110, its extended-release, opioid-sparing post-surgical pain candidate.

About PRF Technologies

PRF Technologies (Nasdaq: PRFX) is a company focused on the reformulation of established therapeutics, and a developer of AI-driven energy optimization technologies through its DeepSolar platform. The Company’s pharmaceutical programs leverage a proprietary extended-release drug-delivery system intended to provide prolonged post-surgical pain relief while minimizing the need for repeated dosing and reducing reliance on opioids. Through DeepSolar and GridFeed, PRF also develops advanced software solutions that enable both consumers and enterprises to monitor, forecast, trade and optimize energy – particularly in solar-integrated environments. This dual business model reflects PRF’s strategic commitment to applying precision technology across high-impact sectors including healthcare and sustainable energy. For more information, please visit www.prf-tech.com.

Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act about PRF’s expectations, beliefs and intentions including with respect to statements related to the proposed license and sale of the DeepSolar/GridFeed platform to Dotz and the related investment by PRF in Dotz, including the expected terms, timing and completion of the proposed transaction; the negotiation and execution of definitive agreements; the satisfaction of the conditions to closing; the receipt of the purchase price and the anticipated benefits of the proposed transaction to PRF, including any reduction in operating costs and the value of any equity position in Dotz; the strategic fit between GridFeed and Dotz’s business and Dotz’s ability to commercialize GridFeed; the Company’s expectations regarding the timing, commencement, enrollment, conduct and results of the planned Phase 2 clinical trial of OcuRing™-K, including the anticipated commencement of patient enrollment before year-end 2026; the potential safety, efficacy, benefits and commercial potential of OcuRing™-K and PRF-110; the Company’s cash resources; and the Company’s ability to execute on its strategic priorities and create long-term shareholder value. Forward-looking statements can be identified by the use of forward-looking words such as “believe”, “expect”, “intend”, “plan”, “may”, “should”, “could”, “might”, “seek”, “target”, “will”, “project”, “forecast”, “continue” or “anticipate” or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including, but not limited to, the following: the non-binding nature of the term sheet and the possibility that definitive agreements will not be executed or that the proposed transaction will not be completed on the expected terms, on the expected timeline, or at all; the ability of Dotz to pay the purchase price installments when due and to obtain the financing it requires; the value, liquidity and volatility of any Dotz securities PRF may acquire, and fluctuations in the exchange rate between the U.S. dollar and the Australian dollar; the receipt of required board, regulatory, stock exchange and third-party approvals and consents; the preliminary and unaudited nature of the cash information included in this press release and the possibility that final reported amounts may differ; our ability to continue as a going concern, our history of significant losses, our need to raise additional capital and our ability to obtain additional capital on acceptable terms, or at all; our dependence on the success of our product candidates, PRF-110 and OcuRing™-K, LayerBio Inc.’s lead product candidate; the outcomes of preclinical studies, clinical trials and other research regarding PRF-110, OcuRing™-K and future product candidates; our limited experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product manufacturing and development; the impact of competition and new technologies; our ability to comply with regulatory requirements relating to the development and marketing of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights and our ability to operate our business without infringing the intellectual property rights of others; the overall global economic environment; our ability to develop an active trading market for our ordinary shares and whether the market price of our ordinary shares is volatile; our ability to maintain our listing on the Nasdaq Capital Market; and statements as to the impact of the political and security situation in Israel on our business. More detailed information about the risks and uncertainties affecting us is contained under the heading “Risk Factors” included in the Company’s most recent Annual Report on Form 20-F and in other filings that we have made and may make with the Securities and Exchange Commission in the future.

Contact:

Crescendo Communications, LLC
Tel: 212-671-1020
Email: prfx@crescendo-ir.com

Dr. Ehud Geller, Chairman
PRF Technologies Ltd.
Tel: +972-54-4236711
Email: egeller@medicavp.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the terms of PRF Technologies’ proposed GridFeed sale to Dotz Nano?

Dotz would commercialize and acquire GridFeed for US$1.0 million, initially operating under an exclusive license from closing. Ownership and intellectual property would transfer once US$650,000 of the purchase price is paid. The term sheet is non-binding; completion requires due diligence, both boards’ approval and definitive agreements.

How would PRF Technologies retain exposure to GridFeed after the proposed sale?

PRF would take an equity position in Dotz through a US$250,000 participation in Dotz’s recently announced A$2.0 million placement. That holding would allow PRF to participate in any value Dotz creates from commercializing the combined technology.

Keep reading